Global COVID-19 Vaccine Market Report By Type (mRNA Vaccine) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2020-2027

ID:VMR11211949
January 2021
Report Formats:
Global COVID-19 Vaccine Market Overview
 
With rapidly increasing cases of COVID-19 worldwide, there exists an urgent need for efficient and reliable drugs and vaccines to treat it. As of now there is no specific drug for the treatment of coronavirus outbreak. Governments across the world are engaged in an intense battle to discover a successful vaccine. Many ongoing clinical trials are analyzing potential treatments. Laboratories and pharmaceutical companies are also actively working on the potential vaccine and treatment. As per the data from WHO, a total of 102 vaccine candidates are in development and 8 have entered the human trial stage.
 
According to Value Market Research, the global COVID-19 Vaccine Market is expected to grow at a CAGR 20% between 2020 and 2026. In late 2019, new coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) infected China. The wave of infection of the SARS-CoV-2 started affecting all the prominent regions and economies across Europe, the Americas, and Asia-Pacific at a rapid pace. Furthermore, SARS-CoV-2 also known as CoVID-19 has a high transmission rate affecting a large portion of the global population. The COVID-19 pandemic has affected lives and businesses on a large scale like never before. The global economy is in the middle of its deepest recession in almost a century and a large population is forced to stay indoors.
 
To overcome this pandemic, many companies are entering into strategic partnerships and collaboration. For instance, GeoVax, a US-based pharmaceutical company, and BravoVax, a China-based pharmaceutical company, have declared plans regarding the development of a coronavirus vaccine based on the former’s MVA-VLP vaccine platform. Major players that rule in the industry are Pfizer, BioNTech, SERUM Institute and others.

Global COVID-19 Vaccine Market Share

In this market research report, the market is segmented by type and region.
 
Analysis by Type
mRNA vaccines can be used as therapeutic vaccines, protein replacement, cancer immunotherapy, and many others. Recently, it is using in the development of the COVID-19 vaccine. Pharmaceutical companies are financing in mRNA technologies as they can combine multiple molecules into a therapeutic medicine, which is acting as another significant growth-inducing factor. Rising cases of COVID-19 across the globe is the primary factor to drive market growth.
 
Analysis by Region
Geographically, the market has been studied across North America, Europe. Asia Pacific, Latin America and Middle East and Africa. Among these, North America is likely to hold largest market share on account of presence of large number manufacturers followed by Europe and Asia. Rising research and development activities and rising healthcare expenditure across the globe is propel demand over the forecast period.
 
Market Segmentation covered in the Report:
By Type
  • mRNA

By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

METHODOLOGY:

This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot
 
3 . COVID-19 VACCINE – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Type
           3.7.2 By Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis
 
6 . GLOBAL COVID-19 VACCINE MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 mRNA Market by Regions
 
7 . GLOBAL COVID-19 VACCINE MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview, Historic and Forecast Data
           7.3.2. North America By Segment
           7.3.3. North America By Country
           7.3.4. United State
           7.3.5. Canada
           7.3.6. Mexico
       7.4. Europe
           7.4.1. Overview, Historic and Forecast Data
           7.4.2. Europe by Segment
           7.4.3. Europe by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7. Italy
           7.4.8. Russia
           7.4.9. Rest Of Europe
       7.5. Asia Pacific
           7.5.1. Overview, Historic and Forecast Data
           7.5.2. Asia Pacific by Segment
           7.5.3. Asia Pacific by Country
           7.5.4. China
           7.5.5. India
           7.5.6. Japan
           7.5.7. South Korea
           7.5.8. Australia
           7.5.9. Rest Of Asia Pacific
       7.6. Latin America
           7.6.1. Overview, Historic and Forecast Data
           7.6.2. Latin America by Segment
           7.6.3. Latin America by Country
           7.6.4. Brazil
           7.6.5. Argentina
           7.6.6. Peru
           7.6.7. Chile
           7.6.8. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview, Historic and Forecast Data
           7.7.2. Middle East & Africa by Segment
           7.7.3. Middle East & Africa by Country
           7.7.4. Saudi Arabia
           7.7.5. UAE
           7.7.6. Israel
           7.7.7. South Africa
           7.7.8. Rest Of Middle East And Africa
 
8 . COMPETITIVE LANDSCAPE OF THE COVID-19 VACCINE COMPANIES
       8.1. Covid-19 Vaccine Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF COVID-19 VACCINE INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Pfizer
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. BioNTech
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. SERUM Institute
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES
 

  •  Market Snapshot
  •  Drivers : Impact Analysis
  •  Restraints : Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  COVID-19 Impact Analysis by Production, Import, Export and Demand
  •  Pre V/S Post COVID-19
  •  Estimated Impact Of The Coronavirus (Covid-19) Epidemic
  •  COVID-19: Micro and Macro Factor Analysis
  •  Analysis by Type (USD MN)
  •  mRNA Market by Geography (USD MN)
  •  Global Covid-19 Vaccine Market by Geography (USD MN)
  •  North America Market Analysis (USD MN)
  •  United State Market Analysis (USD MN)
  •  Canada Market Analysis (USD MN)
  •  Mexico Market Analysis (USD MN)
  •  Europe Market Analysis (USD MN)
  •  Europe Market Estimate by Country (USD MN)
  •  United Kingdom Market Analysis (USD MN)
  •  France Market Analysis (USD MN)
  •  Germany Market Analysis (USD MN)
  •  Italy Market Analysis (USD MN)
  •  Russia Market Analysis (USD MN)
  •  Spain Market Analysis (USD MN)
  •  Rest of Europe Market Analysis (USD MN)
  •  Asia Pacific Market Analysis (USD MN)
  •  China Market Analysis (USD MN)
  •  Japan Market Analysis (USD MN)
  •  India Market Analysis (USD MN)
  •  South Korea Market Analysis (USD MN)
  •  Australia Market Analysis (USD MN)
  •  Rest of Asia Pacific Market Analysis (USD MN)
  •  Latin America Market Analysis (USD MN)
  •  Brazil Market Analysis (USD MN)
  •  Argentina Market Analysis (USD MN)
  •  Peru Market Analysis (USD MN)
  •  Chile Market Analysis (USD MN)
  •  Rest of Latin America Market Analysis (USD MN)
  •  Middle East & Africa Market Analysis (USD MN)
  •  Saudi Arabia Market Analysis (USD MN)
  •  UAE Market Analysis (USD MN)
  •  Israel Market Analysis (USD MN)
  •  South Africa Market Analysis (USD MN)
  •  Rest of Middle East and Africa Market Analysis (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
 
 LIST OF FIGURES
 
  •  Research Scope of Covid-19 Vaccine Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Covid-19 Vaccine Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Market Analysis by Type (USD MN)
  •  mRNA Market by Geography (USD MN)
  •  Global Market by Revenue
  •  North America Market by Revenue
  •  Europe Market by Revenue
  •  Asia Pacific Market by Revenue
  •  Latin America Market by Revenue
  •  Middle East & Africa Market by Revenue
  •  Recent Development in Industry
  •  Company Market Share Analysis, 2020
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials